These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 8543542)

  • 1. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay.
    Frye MA; Altshuler LL; Szuba MP; Finch NN; Mintz J
    J Clin Psychiatry; 1996 Jan; 57(1):17-21. PubMed ID: 8543542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
    J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
    Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
    Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
    Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
    J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-economic implications of the onset of action of antimanic agents.
    Keck PE; McElroy SL; Bennett JA
    J Clin Psychiatry; 1996; 57 Suppl 13():13-8; discussion 19-22. PubMed ID: 8970501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
    Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients.
    Goldberg JF; Garno JL; Leon AC; Kocsis JH; Portera L
    J Clin Psychiatry; 1998 Apr; 59(4):151-8. PubMed ID: 9590664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A medication algorithm for treatment of bipolar rapid cycling?
    Calabrese JR; Woyshville MJ
    J Clin Psychiatry; 1995; 56 Suppl 3():11-8. PubMed ID: 7883737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-lithium treatment for bipolar disorder.
    Post RM
    J Clin Psychiatry; 1990 Aug; 51 Suppl():9-16; discussion 17-9. PubMed ID: 2116406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Has drug treatment of manic disorders changed in clinical routine practice? Retrospective analysis of treatment modalities and results in a university psychiatric clinic].
    Reetz-Kokott U; Müller-Oerlinghausen B
    Nervenarzt; 1996 Mar; 67(3):229-34. PubMed ID: 8901281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
    Dardennes R; Lafuma A; Watkins S
    Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divalproex sodium in the treatment of refractory affective disorders.
    Schaff MR; Fawcett J; Zajecka JM
    J Clin Psychiatry; 1993 Oct; 54(10):380-4. PubMed ID: 8262880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
    Dunner DL
    J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mood stabilizers in hospitalized children with bipolar disorder: a retrospective review.
    Davanzo P; Gunderson B; Belin T; Mintz J; Pataki C; Ott D; Emley-Akanno C; Montazeri N; Oppenheimer J; Strober M
    Psychiatry Clin Neurosci; 2003 Oct; 57(5):504-10. PubMed ID: 12950705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial triple therapy of acute mania, adding lithium and valproate to neuroleptics.
    Reischies FM; Hartikainen J; Berghöfer AM
    Pharmacopsychiatry; 2002 Nov; 35(6):244-6. PubMed ID: 12518274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic exposure in bipolar outpatients in a research setting.
    Denicoff KD; Sollinger AB; Frye MA; Ali SO; Smith-Jackson EE; Leverich GS; Post RM
    Compr Psychiatry; 2000; 41(4):248-52. PubMed ID: 10929791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
    Keck PE; McElroy SL
    J Clin Psychiatry; 2002; 63 Suppl 10():13-7. PubMed ID: 12392348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.